Extra Vitamins Don't Always Fill the Void
Weaker bones that come with menopause might spur some women to load up on calcium and vitamin D. But supplements might not be enough to protect bones and prevent fractures.
Understanding Prader-Willi Syndrome
Some genetic diseases may be very rare, but knowing they exist may help the individuals who have them get medical attention sooner. One such disease is Prader-Willi syndrome.
Surgical Menopause Treatment Options
The average age for natural menopause (a woman's last period) is 51. But some women experience menopause earlier, whether naturally or because of surgery.
Balancing Medication With Pregnancy
When diseases occur during childbearing years, it’s not always possible to stop treatment for the disease. Doctors and patients must balance the concern for the drug's possible effects on pregnancy with the concern for disease relapse.
More Than Hot Flashes
Hot flashes are a biggie among middle-aged women. But common effects of menopause can differ around the world. New research has identified a number of different symptoms among menopausal women with osteoporosis and cardiovascular disease.
Infertility Treatments and MS Don't Mix
Having difficulty conceiving is a reality for 10 to 20 percent of western couples. While some turn towards infertility treatments, those with conditions like multiple sclerosis (MS) may need to exercise caution in these important reproductive decisions.
Move Aside Milk, Alcohol May Help Bone Loss
While the apple can keep the doctor away, alcohol may help keep bones from going away. Researchers say if middle-aged women drink a glass or two of alcohol each day, their bones may be stronger.
Giving Birth is a Gas — Or Not
It's no secret that giving birth is painful. While care providers offer a range of methods to deal with that pain, little is known about one in particular: nitrous oxide.
Subtle Long-Term Impacts of Child Abuse
Experiencing abuse as a child means more than a higher risk of mental illness. Researchers are learning that abused children are at risk for various long-term physical issues as well.
European Drug for Menopause and Osteoporosis
Pfizer Inc. announced that the European Medicines Agency (EMA) accepted for review the Marketing Authorization Application (MAA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for postmenopausal women with a uterus for the treatment of estrogen deficiency symptoms and treatment of osteoporosis in women at risk of fracture.